NO180230C - 2-amino-1,2,3,4-tetrahydronaftalenderivater med kardiovaskulær aktivitet samt farmasöytiske preparater inneholdende slike - Google Patents

2-amino-1,2,3,4-tetrahydronaftalenderivater med kardiovaskulær aktivitet samt farmasöytiske preparater inneholdende slike

Info

Publication number
NO180230C
NO180230C NO934160A NO934160A NO180230C NO 180230 C NO180230 C NO 180230C NO 934160 A NO934160 A NO 934160A NO 934160 A NO934160 A NO 934160A NO 180230 C NO180230 C NO 180230C
Authority
NO
Norway
Prior art keywords
amino
pharmaceutical preparations
preparations containing
cardiovascular activity
tetrahydronaphthalene derivatives
Prior art date
Application number
NO934160A
Other languages
English (en)
Other versions
NO934160D0 (no
NO180230B (no
NO934160L (no
Inventor
Francesco Santangelo
Giorgio Bertolini
Cesare Casagrande
Francesco Marchini
Stefania Montanari
Claudio Semeraro
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of NO934160D0 publication Critical patent/NO934160D0/no
Publication of NO934160L publication Critical patent/NO934160L/no
Publication of NO180230B publication Critical patent/NO180230B/no
Publication of NO180230C publication Critical patent/NO180230C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
NO934160A 1992-03-17 1993-11-17 2-amino-1,2,3,4-tetrahydronaftalenderivater med kardiovaskulær aktivitet samt farmasöytiske preparater inneholdende slike NO180230C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI920608A IT1254521B (it) 1992-03-17 1992-03-17 Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare
PCT/EP1993/000577 WO1993019036A1 (en) 1992-03-17 1993-03-13 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them

Publications (4)

Publication Number Publication Date
NO934160D0 NO934160D0 (no) 1993-11-17
NO934160L NO934160L (no) 1993-11-17
NO180230B NO180230B (no) 1996-12-02
NO180230C true NO180230C (no) 1997-03-12

Family

ID=11362451

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934160A NO180230C (no) 1992-03-17 1993-11-17 2-amino-1,2,3,4-tetrahydronaftalenderivater med kardiovaskulær aktivitet samt farmasöytiske preparater inneholdende slike

Country Status (20)

Country Link
US (2) US5407956A (no)
EP (1) EP0585440B1 (no)
JP (1) JP3231775B2 (no)
KR (1) KR100283945B1 (no)
AT (1) ATE137737T1 (no)
CA (1) CA2102490C (no)
DE (1) DE69302544T2 (no)
DK (1) DK0585440T3 (no)
ES (1) ES2087729T3 (no)
FI (1) FI935066A7 (no)
GR (1) GR3020419T3 (no)
HU (2) HUT68936A (no)
IT (1) IT1254521B (no)
MD (1) MD1449G2 (no)
NO (1) NO180230C (no)
NZ (1) NZ249845A (no)
OA (1) OA09843A (no)
PL (2) PL172056B1 (no)
RU (1) RU2120435C1 (no)
WO (1) WO1993019036A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271411B (it) * 1993-09-14 1997-05-28 Zambon Spa Derivati del 2-ammino-1,2,3,4-tetraidro-naftalene attivi sul sistema cardiovascolare
IT1274673B (it) * 1994-04-14 1997-07-24 Zambon Spa Derivati dell'acido fosfonico utili nel trattamento delle malattie car.iovascolari
IT1270260B (it) * 1994-06-21 1997-04-29 Zambon Spa Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi
IT1271008B (it) * 1994-09-13 1997-05-26 Zambon Spa Derivati del 2-ammino-1,2,3,4-tetraidro-naftalene attivi sul sistema cardiovascolare
IT1271007B (it) * 1994-09-13 1997-05-26 Zambon Spa Derivati del 2-ammino-1,2,3,4-tetraidronaftalene attivi sul sistema cardiovascolare
IT1271009B (it) * 1994-09-13 1997-05-26 Zambon Spa Derivati del benzopirano e del benzotiopirano attivi sul sistema cardiovascolare
IT1273455B (it) * 1995-01-27 1997-07-08 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
IT1276710B1 (it) * 1995-06-14 1997-11-03 Zambon Spa Derivati dell'acido fosfinico ad attivita' inibitrice delle metallopeptidasi
GB9625455D0 (en) * 1996-12-07 1997-01-22 Glaxo Group Ltd Process for resolving mixtures of carbocyclic steroisomers
IT1289980B1 (it) * 1997-02-26 1998-10-19 Zambon Spa Derivati idrossimetilici del 2-ammino-1,2,3,4-tetraidronaftalene attivi in campo cardiovascolare
KR101774598B1 (ko) 2008-12-09 2017-09-04 인터퀴임, 에스.에이. (6s)­(­)­5,6,7,8­테트라하이드로-6-[프로필­(2­티에닐)에틸]아미노­1­나프톨(로티고틴)의 제조를 위한 공정

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072061B1 (en) * 1981-08-05 1985-05-15 FISONS plc Amine derivatives, processes for their production and pharmaceutical compositions containing them
EP0142283B1 (en) * 1983-10-25 1991-01-30 FISONS plc Phenylethylamines, process for their preparation and compositions containing them
IT1224405B (it) * 1987-12-23 1990-10-04 Simes Composti attivi sul sistema cardiovascolare

Also Published As

Publication number Publication date
PL171844B1 (pl) 1997-06-30
IT1254521B (it) 1995-09-25
HUT68936A (en) 1995-08-28
US5451608A (en) 1995-09-19
RU2120435C1 (ru) 1998-10-20
PL172056B1 (pl) 1997-07-31
GR3020419T3 (en) 1996-10-31
AU650201B2 (en) 1994-06-09
JPH06507920A (ja) 1994-09-08
NO934160D0 (no) 1993-11-17
DE69302544D1 (de) 1996-06-13
ITMI920608A0 (it) 1992-03-17
KR100283945B1 (ko) 2001-03-02
HU211517A9 (en) 1995-11-28
NZ249845A (en) 1996-03-26
OA09843A (en) 1994-08-15
US5407956A (en) 1995-04-18
CA2102490C (en) 2004-06-08
AU3747893A (en) 1993-10-21
FI935066L (fi) 1993-11-16
EP0585440B1 (en) 1996-05-08
DE69302544T2 (de) 1996-09-19
NO180230B (no) 1996-12-02
CA2102490A1 (en) 1993-09-18
ATE137737T1 (de) 1996-05-15
JP3231775B2 (ja) 2001-11-26
EP0585440A1 (en) 1994-03-09
FI935066A0 (fi) 1993-11-16
FI935066A7 (fi) 1993-11-16
NO934160L (no) 1993-11-17
ES2087729T3 (es) 1996-07-16
ITMI920608A1 (it) 1993-09-17
MD960271A (en) 1997-09-30
MD1449F1 (en) 2000-04-30
WO1993019036A1 (en) 1993-09-30
MD1449G2 (ro) 2000-12-31
DK0585440T3 (da) 1996-06-10

Similar Documents

Publication Publication Date Title
FI922325A0 (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
NO894630L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
LV10878A (lv) Adas apstradasana ar izveletiem amfifiliem kopolimeriem
FI905531A0 (fi) Transdermalisk anvaendning av 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobensotiazol.
AU4786290A (en) The use of the active substance azelastine in combatting psoriasis disorders and inflammatory disorders
NO934160L (no) 2-amino-1,2,3,4-tetrahydronaftalen-derivater med kardiovaskulaer aktivitet, fremgangsmaate for fremstilling derav samt farmasoeytiske preparater inneholdende slike
NO893909D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
NO891723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
LV11882A (lv) Aminotetralina atvasinajumi sirds un asinsvadu slimibu arstesana
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
ES2087764T3 (es) Uso del ajo de oso en el tratamiento o prevencion de los trastornos circulatorios.
IT1243734B (it) Composizione per uso terapeutico e/o cosmetico per il trattamento di disturbi circolatori e per trattamenti di medicina estetica
NO890607L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater.
FR2578745B1 (fr) Preparations pharmaceutiques fluidifiant le sang
NO961046D0 (no) Fremgangsmåte for behandling av pasienter med akutt hjerteinfarkt som ikke gjennomgår trombolytisk behandling med hirudin og acetylsalicylsyre
DE68912432D1 (de) Pharmazeutische Zusammensetzung, verwendbar bei der Behandlung von Herzgefässerkrankungen.
ES2011230A4 (es) Derivados peptidos del 3 - aminodihidrotiofeno - 2 - uno, procesos para la preparacion y uso terapeutico
NO890724D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO882282D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazin-amider.
FI950951L (fi) Farmaseuttisia aineita veren uudelleenvirtauksesta sydämen läpi aiheutuneen sydänlihasvaurion ja sydänpysähdyksen hoitamiseksi
NO173098C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 10-propynol-androstener
IT8819879A0 (it) Composizioni farmaceutiche atte all'impiego nella terapia dell'ipotensione arteriosa.
IT8420949A0 (it) Farmaco per la terapia dell'ipertensione arteriosa e dell'infarto del miocardio.
NO880841D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
ATE103814T1 (de) Pharmazeutische zusammensetzungen und deren verwendung in der behandlung von entzuendungen.